Terms: = Skin cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
44 results:
1. Acute onset of leukemia cutis in a 70-year-old-patient: a case report.
Selan M; Stopajnik N
Acta Dermatovenerol Alp Pannonica Adriat; 2023 Dec; 32(4):187-189. PubMed ID: 38126102
[TBL] [Abstract] [Full Text] [Related]
2. Blasts with folded nuclei: A histopathologic finding in myeloid leukemia cutis with npm1 and FLT3 mutations.
Han S; Patel T; Garcia ML; Tirado M
J Cutan Pathol; 2024 Feb; 51(2):130-134. PubMed ID: 37866827
[TBL] [Abstract] [Full Text] [Related]
3. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
[TBL] [Abstract] [Full Text] [Related]
4. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
5. CD8/PD-L1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma.
Nishida H; Kondo Y; Kusaba T; Kawamura K; Oyama Y; Daa T
PLoS One; 2023; 18(2):e0281647. PubMed ID: 36780540
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.
Pennington TE; Zhao CY; Colebatch AJ; Fernandez-Peñas P; Guitera P; Burke H; Scolyer RA; Menzies AM; Carlino MS; Lo S; Long GV; Saw RP
Australas J Dermatol; 2022 May; 63(2):e133-e137. PubMed ID: 35188271
[TBL] [Abstract] [Full Text] [Related]
7. Complete Bone Marrow Necrosis with Charcot-Leyden Crystals Caused by Myeloid Neoplasm with Mutated npm1 and TET2.
Saito K; Sato T; Notohara K; Nannya Y; Ogawa S; Ueda Y
Intern Med; 2022 Nov; 61(21):3265-3269. PubMed ID: 35185048
[TBL] [Abstract] [Full Text] [Related]
8. npm1 and FLT3-TKD mutations are enriched in patients with leukemia cutis.
Karagounis TK; Rotemberg V; Geskin LJ; Jurcic JG; MDAuthors GN
Dermatol Online J; 2020 Jul; 26(7):. PubMed ID: 32898396
[TBL] [Abstract] [Full Text] [Related]
9. Dactinomycin in acute myeloid leukemia with npm1 mutations.
Beziat G; Tavitian S; Bertoli S; Huguet F; Largeaud L; Luquet I; Vergez F; Rieu JB; Bories P; Delabesse E; Récher C
Eur J Haematol; 2020 Sep; 105(3):302-307. PubMed ID: 32452083
[TBL] [Abstract] [Full Text] [Related]
10. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
[TBL] [Abstract] [Full Text] [Related]
11. [Features of the Structure and Expression of npm and NCL Genes in Cutaneous Melanoma].
Ponkratova DA; Lushnikova AA
Mol Biol (Mosk); 2019; 53(4):663-673. PubMed ID: 31397440
[TBL] [Abstract] [Full Text] [Related]
12. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
13. New primary melanoma in a patient under triple therapy with vemurafenib, cobimetinib, and atezolizumab for metastatic melanoma.
Diamantopoulos PT; Lakiotaki E; Kyriakakis G; Gogas H
Melanoma Res; 2020 Apr; 30(2):206-208. PubMed ID: 31157737
[TBL] [Abstract] [Full Text] [Related]
14. Blastic plasmacytoid dendritic cell neoplasm arising from clonal hematopoiesis.
Suma S; Sakata-Yanagimoto M; Nguyen TB; Hattori K; Sato T; Noguchi M; Nannya Y; Ogawa S; Watanabe R; Fujimoto M; Nakamura N; Kusakabe M; Nishikii H; Kato T; Chiba S
Int J Hematol; 2018 Oct; 108(4):447-451. PubMed ID: 29705980
[TBL] [Abstract] [Full Text] [Related]
15. Proteomic Analysis and Functional Studies of Baicalin on Proteins Associated with skin cancer.
Li D; Lin B; Yusuf N; Burns EM; Yu X; Luo D; Min W
Am J Chin Med; 2017; 45(3):599-614. PubMed ID: 28385077
[TBL] [Abstract] [Full Text] [Related]
16. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract] [Full Text] [Related]
17. Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling.
Xian J; Shao H; Chen X; Zhang S; Quan J; Zou Q; Jin H; Zhang L
Int J Biol Sci; 2016; 12(2):144-55. PubMed ID: 26884713
[TBL] [Abstract] [Full Text] [Related]
18. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.
Yeh I; de la Fouchardiere A; Pissaloux D; Mully TW; Garrido MC; Vemula SS; Busam KJ; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2015 May; 39(5):581-91. PubMed ID: 25602801
[TBL] [Abstract] [Full Text] [Related]
19. A novel recurrent npm1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.
Velusamy T; Kiel MJ; Sahasrabuddhe AA; Rolland D; Dixon CA; Bailey NG; Betz BL; Brown NA; Hristov AC; Wilcox RA; Miranda RN; Medeiros LJ; Jeon YK; Inamdar KV; Lim MS; Elenitoba-Johnson KS
Blood; 2014 Dec; 124(25):3768-71. PubMed ID: 25349176
[TBL] [Abstract] [Full Text] [Related]
20. Incidence of new primary melanomas after diagnosis of stage III and IV melanoma.
Zimmer L; Haydu LE; Menzies AM; Scolyer RA; Kefford RF; Thompson JF; Schadendorf D; Long GV
J Clin Oncol; 2014 Mar; 32(8):816-23. PubMed ID: 24297954
[TBL] [Abstract] [Full Text] [Related]
[Next]
